Journals / MN Kardiyoloji / 2001 / Cilt: 8 - Sayı: 2

The roles of CRP, fibrinogen and chlamydia in different clinical types of coronary artery disease

Koroner arter hastalığının değişik klinik yelpazelerinde C-reaktif protein, fibrinojen ve klamidyaların rolü

Pages
97–101
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Besides there is no relation between fibrinogen levels and acute coronary sendroms, and between serologic marker of Chlamydia or Mycoplasma and coronary artery disease

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Inflamation may contribute to the progression of atherosclerosis.
📊
Key Findings & Data:On purpose was to compare CRP and fibrinogen levels, detected by termodymetric and coagulometric techniques, between patients who have angiographically proven coronary artery disease and its subgroups (group 1, n=95), with patients who have normal coronary angiograms (group 2, n=30) and also with healthy volunteers (group 3 n=35).
💡
Conclusion & Impact:Besides there is no relation between fibrinogen levels and acute coronary sendroms, and between serologic marker of Chlamydia or Mycoplasma and coronary artery disease
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fibrinojen · C-reaktif protein · Koroner hastalık

Abstract

Inflamation may contribute to the progression of atherosclerosis. However the relation between higher C-reactive protein (CRP), fibrinogen or serologic levels of Chlamydia and risk of coronary artery disease is still controversial. On purpose was to compare CRP and fibrinogen levels, detected by termodymetric and coagulometric techniques, between patients who have angiographically proven coronary artery disease and its subgroups (group 1, n=95), with patients who have normal coronary angiograms (group 2, n=30) and also with healthy volunteers (group 3 n=35). CRP levels were found higher in group 1 than in group 2 and 3 (respectively, 14.5±20 mg/L, 7.5±10 mg/L). CRP levels were higher in the subgroups of group 1, who had acute myocardial infarction (MI), recent MI (within last two months after discharge) and unstable angina pectoris (respectively, 28.6±29mg/L p<0.05, 9.1±12mg/L p=NS, 16.7±19mg/L p<0.05). However in stable angina pectoris subgroup of group1, CRP levels were close to group 2 and 3 (5.5±7.7 mg/L ve 5.3±3.6 mg/L and 7.5±10.2). The difference between fibrinojen levels was statistically significant only between group 3 and acute MI subgroup. Besides Chlamydia and Mycoplasma levels between groups had no statistically significant data. Indeed such a positive correlation between CRP and fibrinogen levels (r=0.35, p<0.01)could not be detected between Chlamydia and Mycoplasma serologies. Conclusively we have suggested that although there is a strong relation between acute coronary syndromes and CRP levels, CRP dose not have a potential role to detect chronic stable coronary disease. Besides there is no relation between fibrinogen levels and acute coronary sendroms, and between serologic marker of Chlamydia or Mycoplasma and coronary artery disease

Özet

İnflamasyon atheroskleroz gelişimine katkıda bulunabilir. Ancak yüksek C-reaktif protein (CRP), fibrinojen ve klamidya serolji düzeyleri ile koroner olay riskleri arasında oldukça çelişkili sonuçlar bildirilmiştir ve bu konu hala tartışılmaktadır. Bu amaçla, CRP ve fibrinojen değerlerini, koroner arter hastalığı anjiyografik olarak gösterilen hastalar ve bunların alt gruplarıyla, sağlıklı gönüllüler ve koroner anjiyografi sırasında koroner arterleri normal çıkan hastalar arasında karşılaştırdık. Koroner arter hastalığı olan 95 hasta (grup 1), normal koroner anjiyografili 30 hasta (grup 2) ve 35 sağlıklı gönüllü kontrol hastanın (grup 3) CRP ve fibrinojen düzeyleri tubidimetric ve kuagulometric metod ile değerlendirildi. Grup 1'in CRP düzeyi grup 2 ve 3'e göre daha yüksekti (sırasıyla 14.5±20 mg/L, 7.5±10 mg/L; p<0,05 grup 1ve 3'e göre ve 2.3±3.6 mg/L; p<0.001grup 1'e göre). Grup 1 içindeki akut miyokard infarktüsü (MI) geçiren (28.6±29 mg/L p<0.01) yada son iki ay içinde MI geçirmiş olan (9.1±12mg/L p=NS) ve unstabil anjina pektorisili (16,7±19mg/L p<0,05) hastaları içeren alt gruplarda CRP seviyesi daha yüksekti. Ancak grup 1 içinde stabil anjina pektorisi olan alt grubun CRP düzeyi hem sağlıklı kontrol grubuyla (5.5±7.7 mg/L ve 5.3±3.6 mg/L) hem de koroner anjiyosu normal olanlarla benzer idi. Fibrinojen düzeyleri ise grup 1 ve 2 de sağlıklı gönüllülere göre daha yüksek olmakla birlikte kendi aralarında ve grup 1'in alt grupları arasında anlamlı farklılık yoktu. Ayrıca Klamidya ve Mikoplazma serolojileri ile koroner arter hastalığı arasında hiçbir grupta ilişki bulunamadı. CRP ve fibrinojen düzeyi arasında pozitif korelasyon olduğu halde (r=0.35 p<0.01), klamidya ve mikoplazma serolojileri ile CRP arasında böyle bir korelasyon yoktu. Sonuç olarak, koroner arter hastalığının akut koroner sendrom alt gruplarıyla, CRP arasında kuvvetli ilişki olmasına rağmen, kronik stabil koroner hastalıklarını belirlemede CRP'nin potansiyel bir rolünün olmadığı tespit edildi. Fibrinojenin ise akut koroner sendromları belirlemede anlamlı rolü yoktur. Koroner arter hastalığı ile klamidya ve mikoplazmalar arasında da herhangi bir ilişki bulunamamıştır.

🔖

Cite This Article

KARADEDE, A. A., ÖZTÜRK, Ö., AYDINALP, Ö., ÜLGEN, S., KARABULUT, A., TOPRAK, N. (2001). The roles of CRP, fibrinogen and chlamydia in different clinical types of coronary artery disease. MN Kardiyoloji, Cilt: 8 - Sayı: 2, 97–101. https://ajindex.com/articles/297732

References (11)

  1. Alexander RW. Inflammation and coronary artery disease [editorial]. N Engl J Med 1994
  2. Ernest E. Fibrinogen as a cardiovascular risk factor: interrelationship with infections and inflammation. Eur Heart J 1994
  3. Heinrich J, Schulte H, Schönfeld R, Köhler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemostas 1995
  4. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997
  5. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995
  6. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996:144:537. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997
  7. Liuzzo G, Biassucci LM, Gallimore JR, et al. Prognostic value of C- reactive protein and plasma amyloid A protein in unstable angina. New Engl J Med 1994
  8. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998:98:731. Herity NA. Interleukin 6: a message from the heart. Heart 2000:84:9. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993:87:1130. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995
  9. Cermak J, Key NS, Bach RR, Balla J, Jacobs HSrVercellotti GM. C- reactive protein induces human peripheral blood, monocytes to synthesize tissue factor. Blood 1993
  10. Otsuji S, Shibata H, Umeda M. Turbidimetric immunoassay of serum C-reactive protein. Clin Chem 1982 Oct
  11. Yarnell JWC, Baker IA, Sweetnam PM, Dainton D, O'Brian J, Whitehead P, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for i